Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03274986 · ClinicalTrials.gov registry record · NA
A Clinical Study of the ACRYSOF® IQ Extended Depth of Focus Intraocular Lens (IOL)
A NA study of Cataract, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
- 11
- Study locations
NCT03274986 is a NA study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 242 participants, roughly in line with the 225-participant average among 83 other Cataract trials with a reported enrollment target. The trial reports 11 study locations across 8 states.
The verdict
NCT03274986, a NA study of Cataract, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of the study is to demonstrate the safety and performance of ACRYSOF IQ extended depth of focus (EDF) intraocular lens (IOL) at Month 6. Depth of focus (DOF) is the amount of focal plane displacement behind a lens that does not degrade the image quality of a distant object. A larger DOF allows sharp images of closer objects and may provide improved vision at intermediate and near distances.
Conditions Studied
Interventions
- PROCEDURE Cataract surgery
- DEVICE ACRYSOF® IQ Extended Depth of Focus IOL
- DEVICE ACRYSOF® IQ Monofocal IOL
Study Locations (11)
Pennsylvania
- Alcon Investigative Site - Allenwood
- Alcon Investigative Site - Kingston
- Alcon Investigative Site - West Mifflin
Florida
- Alcon Investigative Site - Bradenton
- Alcon Investigative Site - Sebring
Alabama
- Alcon Investigative Site - Birmingham
Colorado
- Alcon Investigative Site - Fort Collins
Georgia
- Alcon Investigative Site - Gainesville
Illinois
- Alcon Investigative Site - Rock Island
Ohio
- Alcon Investigative Site - Cincinnati
South Dakota
- Alcon Investigative Site - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2017-10-11 |
| Est. Completion | 2018-10-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03274986
The ClinicalTrials.gov registry entry for NCT03274986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 225-participant average among 83 other Cataract trials with a reported enrollment target. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 3 interventions - of which Cataract surgery is the first listed.
NCT03274986 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Pennsylvania, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT03274986 about?
NCT03274986 is a clinical study titled "A Clinical Study of the ACRYSOF® IQ Extended Depth of Focus Intraocular Lens (IOL)". The purpose of the study is to demonstrate the safety and performance of ACRYSOF IQ extended depth of focus (EDF) intraocular lens (IOL) at Month 6. Depth of focus (DOF) is the amount of focal plane displacement behind a lens that does not degrade the image quality of a distant object. A larger DOF ...
What is the current status of trial NCT03274986?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2017-10-11. Estimated completion is 2018-10-16.
What conditions does trial NCT03274986 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT03274986?
The interventions under investigation include: Cataract surgery (PROCEDURE), ACRYSOF® IQ Extended Depth of Focus IOL (DEVICE), ACRYSOF® IQ Monofocal IOL (DEVICE).
Who is sponsoring clinical trial NCT03274986?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03274986 being conducted?
This trial has 11 study locations across Alabama, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.